Boy, this is really sad considering the great advancements that are taking place in our system that drugs that have been used for ages get left behind, which I assume is part of the problem. Can you describe for our audience what the Civica model is? How you assess what drugs ought to be considered for your purposes, and then what’s the relationship between how you produce or license those drugs and how you get them to the bedside?